USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Overview Mobile PortfolioWidgetsBacktestingToolsetFinancial ContentInvestment Grader

US Market Closed: Feb 8, 03:29 AM 2012

NYSE 8069.71 NASDAQ 2904.08

and more..

sponsered by

Processing
Collecting necessary data for BVF and NKTR...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Biovail Corp. Common Stoc and

Nektar Therapeutics

Volatility

Matrix

Run Correlation

Diversification

Pay attention

Overlapping area represents amount of risk that can be diversified away by holding Biovail Corp. Common Stoc and Nektar Therapeutics in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

0.0

Parameters

Time Period	1 Month [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Suggest

Biovail Corporation Common Stoc

Profile

0.0

Intraday

One Month

^0.00

0.00%

BVF

NYSE

Biovail Corporation Common Sto

Nektar Therapeutics

Profile

7.27

Intraday

One Month

^0.00

0.00%

NKTR

NASDAQ

Nektar Therapeutics

P/B Ratio	3.60	Market Cap	831.9M
Sector	Healthcare	Last Close	7.27
Short Ratio	14.90	Last Traded	2/7/2012
Year High	11.25	Change (%)	Not Applicable
EBITDA	-82.0M	Year Low	4.07
Book Value	2.017	EPS	-1.103
Employees	408	High	Not Applicable
Target Price	10.67	Current EPS	-1.103
This Year EPS	-1.33	Next Year EPS	-1.38